Josselin Caradec

Company: ThirtyFiveBio
Job title: Head of Biology
Seminars:
Deciphering GPR35: A Novel Target for Epithelial-Driven Therapeutics in IBD 1:30 pm
Unravelling the role of GPR35 in epithelial biology to address inflammatory bowel disease progression Investigating the therapeutic potential of GPR35 antagonists in preclinical models and patient-derived systems Exploring the use of biomarkers to stratify patients for targeted therapeutic interventions and enhanced clinical outcomesRead more
day: Day Two